MedTrace Logo

Targeting Staphylococci in Atopic Dermatitis

NCT05502185 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2022-08-16

No results posted yet for this study

Summary

The aim of the study is to deliver a better understanding of the molecular mechanisms used by S. epidermidis strains in their adhesion and colonization on the stratum corneum across a broad spectrum of atopic dermatitis in mild to moderate conditions in adult patients.

Conditions

Sponsors & Collaborators

  • L'Oreal

    lead INDUSTRY

Principal Investigators

  • Alan IRVINE, MD · Clinical Research Facility in Trinity College of Dublin/St. James Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-09-01
Primary Completion
2023-09-01
Completion
2023-09-01

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05502185 on ClinicalTrials.gov